Susquehanna Fundamental Investments, LLC Protalix Bio Therapeutics, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.03 - $1.24 $42,821 - $51,551	-41,574 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.81 - $1.17 $1,074 - $1,551	-1,326 Reduced 3.09%	41,574 $44,000
Q4 2021 Feb 14, 2022	SELL	$0.81 - $1.33 $13,446 - $22,078	-16,600 Reduced 27.9%	42,900 $36,000
Q3 2021 Nov 15, 2021	SELL	$1.31 - $1.87 $8,646 - $12,342	-6,600 Reduced 9.98%	59,500 $79,000
Q2 2021 Aug 11, 2021	BUY	$1.86 - $6.22 $122,946 - $411,142	66,100 New	66,100 $126,000

9.27M

40.6K

10.1K

Ticker PLX
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,753,400
Market Cap $53.7M
Description
Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.